Bumper Offer - Urjas oil Just @ Rs. 1
Oflomac, a prescription drug, is manufactured in various forms such as Suspension,Drops,Tablet,Injection,Iv Fluid. It is typically used for the treatment of Urinary Tract Infection, Ear Infection, Bacterial Infections. Secondary and off-label uses of Oflomac have also been mentioned below.
The right dosage of Oflomac depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Some other side effects of Oflomac have been listed ahead. Usually, these side effects of Oflomac go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Oflomac has a Moderate effect for pregnant women and Moderate effect on lactating mothers. Further, the section on Oflomac related warnings talks about Oflomac's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Atrial Fibrillation, Heart Failure, Myasthenia Gravis (MG) must refrain from the use of Oflomac since this can cause severe adverse effects. Other conditions have been mentioned below in the Oflomac contraindications section.
Drug interactions for Oflomac have been reported in the medical literature. See below for a complete list.
In addition to the above precautions for Oflomac, it is important to know that it is not safe while driving, and is not habit-forming.
Oflomac is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
Based on research, the following side effects have been observed when Oflomac is used -
Severe
Moderate
Mild
Is the use of Oflomac safe for pregnant women?
Oflomac may have some side effects during pregnancy. Pregnant women should discontinue the use of Oflomac, and talk to their doctor, if they notice any discomfort.
Is the use of Oflomac safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Oflomac. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Oflomac on the Kidneys?
Oflomac has very mild side effects on the kidneys.
What is the effect of Oflomac on the Liver?
Oflomac has very mild side effects on the liver.
What is the effect of Oflomac on the Heart?
Oflomac may have mild side effects on the heart. Most people will never see any effect on the heart.
Oflomac should not be taken with following medicines due to severe side effects it may cause to patients -
Life Threatening
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Oflomac unless your doctor advises you to do so -
Is this Oflomac habit forming or addictive?
Oflomac is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Oflomac you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Oflomac should be used only after doctor's advice.
Is it able to treat mental disorders?
Oflomac is unable to treat or cure mental disorders.
Interaction between Food and Oflomac
Some foods when eaten with Oflomac can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Oflomac
Consumption of alcohol and Oflomac together may have severe effects on your health.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1400
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 713
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Floxin® (ofloxacin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ocuflox® (ofloxacin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1400
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 713
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Floxin® (ofloxacin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ocuflox® (ofloxacin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1400
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 713
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Floxin® (ofloxacin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ocuflox® (ofloxacin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1400
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 713
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Floxin® (ofloxacin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ocuflox® (ofloxacin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1400
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 713
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Floxin® (ofloxacin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ocuflox® (ofloxacin)
